- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Background simvastatin at a stable dose of 40 mg qHS
Total 35 results
-
AngiogenixUnknownPeripheral Arterial Disease | Intermittent ClaudicationRussian Federation
-
Gamaleya Research Institute of Epidemiology and...Not yet recruitingGram-Negative Bacterial Infections | Bacteremia Caused by Gram-Negative Bacteria | Gram Negative Pneumonia
-
ViriomNot yet recruitingInfluenzaRussian Federation
-
International Bio serviceNot yet recruiting
-
University of IoanninaCompletedComparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)HypercholesterolemiaGreece
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbHCompleted
-
Ottawa Heart Institute Research CorporationHeart and Stroke Foundation of OntarioCompleted
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Rambam Health Care CampusBoehringer IngelheimUnknownHeart Failure | Diabetes Mellitus | Arrythmia
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Enteris BioPharma Inc.Syneos Health; ParexelRecruitingEndometriosisUnited States
-
University Hospital, CaenCompleted
-
Kadmon Corporation, LLCQuotient SciencesCompletedFibrosis | Autoimmune DiseasesUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisNovartisCompleted
-
Egyptian Liver HospitalWadi El Nil HospitalCompleted
-
Centre Hospitalier Universitaire DijonCompletedChild-Pugh A Hepatocellular CarcinomaFrance
-
AstraZenecaCompletedHealthy Subjects | BioavailabilityGermany
-
Fujian Cancer HospitalNot yet recruiting
-
Spanish Clinical Pharmacology SocietySpanish reumatology SocietyCompleted
-
AstraZenecaCompletedHypertriglyceridemiaUnited States
-
Peking Union Medical College HospitalRecruiting
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
AstraZenecaCompletedPharmacokinetics | Bioequivalence | Healthy Japanese SubjectsUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Novartis PharmaceuticalsCompletedDepressive Disorder, Treatment-ResistantSpain, United States
-
Kafrelsheikh UniversityRecruiting
-
Hospital for Special Surgery, New YorkCompletedTotal Hip ReplacementUnited States
-
Cairo UniversityAhmed Elgazzar HospitalCompleted
-
Ayman H QasrawiAstellas Pharma IncWithdrawn
-
Kartal City HospitalRecruiting
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
King's College Hospital NHS TrustKing's College London; Fight for Sight (Funder)RecruitingEye Diseases | Macular Degeneration, Wet | Sub-Macular HemorrhageUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted